Vincent Moutardier, MD

Articles by Vincent Moutardier, MD

Impact of UFT on Tumoral TS and DPD Levels in Colorectal Cancer

ByGerard Bastian, PhD,Jean-franÇois Seitz, MD,Vincent Moutardier, MD,Jean Robert Delperro, MD,Pierre Fargeot, MD,Jean Fraisse, MD,Patricia Formento, PhD,Michel Chazard, MD,Nicole Renée, PhD,Gerard Milano, PhD

October 1st 2000

This was an open lable, pilot translational clinical pharmacology study of a brief (7 day) course of UFT, 300 mg/m²/day, in combination with leucovorin, 90 mg/day, in six patients with newly diagnosed advanced colorectal cancer.

Latest Updated Articles

Impact of UFT on Tumoral TS and DPD Levels in Colorectal Cancer
October 1st 2000

Trending on CancerNetwork

AI and MRD Take Center Stage on Day 2 of ASCO Breakthrough 2026

Pirtobrutinib Earns Positive CHMP Opinion Across All CLL Treatment Lines

GLP-1 Receptor Agonists Reduce Colorectal Cancer Risk in IBD Populations

41 Unexpected While Expecting: Rare Case of Pregnancy Associated Xanthogranulomatous Mastitis Masquerading as Malignancy

42 Intraoperative Frozen Analysis of Sentinel Lymph Nodes After Neoadjuvant Chemotherapy Does Not Provide Additional Surgical Benefit and Increases the Rate of Unnecessary ALND in Clinically Node-Negative Breast Cancer Patients